CONSOLIDATED STATEMENT OF CASH FLOWS - USD ($) $ in Thousands		12 Months Ended
		Apr. 29, 2023	Apr. 30, 2022	Apr. 24, 2021
Cash flows from operating activities
Net income		$ 151,941	$ 152,328	$ 107,529
Adjustments to reconcile net income to cash provided by operating activities
(Gain)/loss on disposal and impairment of assets		6,365	(13,657)	(37)
(Gain)/loss on sale of investments		148	(478)	(954)
Provision for doubtful accounts		1,546	(617)	(3,169)
Depreciation and amortization		40,193	39,771	33,021
Amortization of right-of-use lease assets		76,511	72,942	65,571
Lease impairment		1,347	0	0
Equity-based compensation expense		12,458	11,858	12,671
Change in deferred taxes		3,895	1,022	8,790
Change in receivables		53,675	(41,829)	(38,288)
Change in inventories		32,311	(72,022)	(40,727)
Change in other assets		24,377	(16,232)	2,926
Change in payables		4,586	6,326	37,068
Change in lease liabilities		(77,811)	(73,805)	(65,881)
Change in other liabilities		(126,375)	13,397	191,397
Net cash provided by operating activities		205,167	79,004	309,917
Cash flows from investing activities
Proceeds from disposals of assets		136	22,588	2,770
Capital expenditures		(68,812)	(76,580)	(37,960)
Purchases of investments		(9,092)	(34,152)	(39,584)
Proceeds from sales of investments		24,483	36,096	36,071
Acquisitions		(16,835)	(26,323)	(2,000)
Net cash used for investing activities		(70,120)	(78,371)	(40,703)
Cash flows from financing activities
Payments on debt and finance lease liabilities		(123)	(121)	(75,050)
Holdback payments for acquisitions		(5,000)	(23,000)	(5,783)
Stock issued for stock and employee benefit plans, net of shares withheld for taxes		2,857	(1,818)	9,030
Repurchases of common stock		(5,004)	(90,645)	(44,202)
Dividends paid to shareholders		(29,869)	(27,717)	(16,542)
Dividends paid to minority interest joint venture partners	[1]	0	(1,260)	(8,507)
Net cash used for financing activities		(37,139)	(144,561)	(141,054)
Effect of exchange rate changes on cash and equivalents		(86)	(1,919)	3,015
Change in cash, cash equivalents and restricted cash		97,822	(145,847)	131,175
Cash, cash equivalents and restricted cash at beginning of period		248,856	394,703	263,528
Cash, cash equivalents and restricted cash at end of period		346,678	248,856	394,703
Supplemental disclosure of non-cash investing activities
Capital expenditures included in accounts payable		$ 8,208	$ 9,234	$ 4,638

[1] Includes dividends paid to joint venture minority partners resulting from the repatriation of dividends from our foreign earnings that we no longer consider permanently reinvested.